Financials
- Market Capitalization 1.8 B
- Employee 264
- Founded 2003
- CEO Kenneth Galbraith
- Website www.zymeworks.com
- Headquarter Delaware, United States
- FIGI BBG019XSYC89
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2059 | ZBIO Zenas BioPharma, Inc. - Common Stock | 28.78 USD | +3.23% | +5.19% | +53.41% | +8.77% | 1.82 B USD | ||
| 2060 | STOK Stoke Therapeutics, Inc. - Common Stock | 29.13 USD | -1.12% | -11.32% | -3.96% | +146.24% | 1.81 B USD | ||
| 2072 | AAPG Ascentage Pharma Group International - American Depository Shar | 19.24 USD | -1.94% | +4.96% | +13.11% | -23.04% | 1.80 B USD | ||
| 2084 | RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.34 USD | +1.21% | -9.97% | +2.14% | -36.86% | 1.77 B USD |
Frequently asked questions about Zymeworks Inc. - Common Stock
What is the Zymeworks Inc. - Common Stock stock price today?
The current price of Zymeworks Inc. - Common Stock (ZYME) is 24.66. Over the past 24 hours, the stock has changed by -1.12%. Follow the ZYME chart for real-time price dynamics.
What is the stock ticker of Zymeworks Inc. - Common Stock?
Zymeworks Inc. - Common Stock trades under the ticker ZYME. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Zymeworks Inc. - Common Stock stock going up?
ZYME has changed by -7.36% over the last week, +5.84% over the last month, and +39.01% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Zymeworks Inc. - Common Stock net income for the last quarter?
Zymeworks Inc. - Common Stock reported net income of -44.16 M for the last quarter. The previous quarter showed -41.21 M, which means net income changed by -7.17%.
How many employees does Zymeworks Inc. - Common Stock have?
As of the latest available data, Zymeworks Inc. - Common Stock has 264 employees. Workforce size can provide additional context about the company's scale and operations.
What is Zymeworks Inc. - Common Stock EBITDA?
Zymeworks Inc. - Common Stock EBITDA is -45.19 M, and its EBITDA margin is -1 876.54%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Zymeworks Inc. - Common Stock stock?
You can buy Zymeworks Inc. - Common Stock (ZYME) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Zymeworks Inc. - Common Stock stock?
Investing in Zymeworks Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ZYME chart and related analysis on metatrader.com as part of your research.